Supplementary Figure S1 from Enhancing Therapeutic Efficacy of Oncolytic Herpes Simplex Virus-1 with Integrin β1 Blocking Antibody OS2966Tae Jin Lee, Ji Young Yoo, Mitra Nair et al.|Unknown|2023Cited by 0
Supplementary Figure S3 from Enhancing Therapeutic Efficacy of Oncolytic Herpes Simplex Virus-1 with Integrin β1 Blocking Antibody OS2966Tae Jin Lee, Ji Young Yoo, Mitra Nair et al.|Unknown|2023Cited by 0
Supplementary Figure S4 from Enhancing Therapeutic Efficacy of Oncolytic Herpes Simplex Virus-1 with Integrin β1 Blocking Antibody OS2966Tae Jin Lee, Ji Young Yoo, Mitra Nair et al.|Unknown|2023Cited by 0
Supplementary Figure S3 from Enhancing Therapeutic Efficacy of Oncolytic Herpes Simplex Virus-1 with Integrin β1 Blocking Antibody OS2966Tae Jin Lee, Ji Young Yoo, Mitra Nair et al.|Unknown|2023Cited by 0
Supplementary Figure S2 from Enhancing Therapeutic Efficacy of Oncolytic Herpes Simplex Virus-1 with Integrin β1 Blocking Antibody OS2966Tae Jin Lee, Ji Young Yoo, Manish K. Aghi et al.|Unknown|2023Cited by 0